Clinical Trials on Myelodysplastic Syndromes in New Zealand
Total 4016 results
-
AbbVieCelgene; Genentech, Inc.CompletedMyelodysplastic Syndromes (MDS)United States, Australia, Germany
-
Rigel PharmaceuticalsRecruitingLow Risk Myelodysplastic SyndromesUnited States
-
Otsuka Australia Pharmaceutical Pty LtdRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Patient PreferenceNew Zealand, Australia
-
Weill Medical College of Cornell UniversityNovartis PharmaceuticalsCompletedMyelodysplastic Syndrome (MDS)United States
-
Sumitomo Pharma America, Inc.TerminatedAnemia in Myelodysplastic SyndromesUnited States
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
TelikTerminatedMyelodysplastic Syndrome (MDS)United States
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI)RecruitingMyelodysplastic Syndromes (MDS)United States, Israel
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromesUnited States, France, Germany
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic SyndromesCanada, United States
-
BeiGeneRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelodysplastic/Myeloproliferative NeoplasmChina, United States, Australia, Spain, Korea, Republic of, New Zealand, Germany
-
Hackensack Meridian HealthTerminatedAcute Myeloid Leukemia and Myelodysplastic SyndromeUnited States
-
Incyte CorporationTerminatedMDS (Myelodysplastic Syndrome)United States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; YUKIGUNI COMPANYCompletedMyelodysplastic SyndromeUnited States
-
Keros Therapeutics, Inc.RecruitingMyelodysplastic Syndromes | CytopeniaAustralia, Spain, United States, Israel, France, Germany, New Zealand, Czechia
-
TelikTerminatedMyelodysplastic Syndrome (MDS)United States
-
Memorial Sloan Kettering Cancer CenterCompletedAcute Myeloid Leukemia | Advanced Myelodysplastic SyndromesUnited States
-
Novartis PharmaceuticalsRecruitingMyelodysplastic Syndrome (MDS)United States
-
TelikCompletedMyelodysplastic Syndrome (MDS)United States
-
Seagen Inc.CompletedMyelodysplastic Syndrome (MDS)United States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic SyndromesUnited States
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Columbia University; Karyopharm Therapeutics IncCompletedMyelodysplastic SyndromesUnited States
-
Columbia UniversityCelgene CorporationActive, not recruiting
-
Onconova Therapeutics, Inc.Withdrawn
-
National Cancer Institute (NCI)Active, not recruiting
-
Weill Medical College of Cornell UniversitySunesis PharmaceuticalsCompletedVosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based TherapyMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCompletedMyelodysplastic SyndromeUnited States
-
Montefiore Medical CenterAlbert Einstein College of MedicineWithdrawnMyelodysplastic SyndromesUnited States
-
Roswell Park Cancer InstituteGenzyme, a Sanofi CompanyTerminatedMyelodysplastic SyndromeUnited States
-
University of RochesterCompletedMyelodysplastic SyndromesUnited States
-
Weill Medical College of Cornell UniversityCelgeneTerminatedMyelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityCTI BioPharmaCompletedMyelodysplastic SyndromeUnited States
-
Onconova Therapeutics, Inc.WithdrawnMyelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Actinium PharmaceuticalsCompletedLeukemia | Myelodysplastic SyndromeUnited States
-
Weill Medical College of Cornell UniversityJazz PharmaceuticalsCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Relapsed Adult Acute Myeloid | Myelodysplastic Syndromes, Previously TreatedUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Onconova Therapeutics, Inc.CompletedMyelodysplastic SyndromeUnited States
-
Heinrich-Heine University, DuesseldorfTerminatedMyelodysplastic Syndrome MDSGermany
-
Sumitomo Pharma America, Inc.TerminatedMyelodysplastic Syndromes (MDS)United States
-
NYU Langone HealthPerlmutter Cancer CenterCompletedMyelodysplastic SyndromesUnited States
-
Kura Oncology, Inc.Terminated
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMyelodysplastic Syndromes (MDS) | Acute Myelogenous Leukemia (AML)United States
-
Mirati Therapeutics Inc.CompletedMyelodysplastic SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
University of RochesterNot yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelofibrosis | Myeloid Malignancy | Myelodysplastic/Myeloproliferative NeoplasmUnited States
-
Astex Pharmaceuticals, Inc.TerminatedMyelodysplastic SyndromesUnited States
-
Opsona Therapeutics Ltd.M.D. Anderson Cancer Center; Montefiore Medical Center; New York Presbyterian... and other collaboratorsCompletedMyelodysplastic SyndromeUnited States